Safety Information about Medications for ADHD

• FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
  12/12/2011
• FDA Drug Safety Podcast for Healthcare Professionals: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
  12/2011
• FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
  11/1/2011
• FDA Drug Safety Podcast for Healthcare Professionals: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
  11/1/2011
• Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad de medicamentos usados para el tratamiento del Trastorno de Déficit de Atención con Hiperactividad (ADHD por sus siglas en inglés) en niños y adultos jóvenes
  11/2011
• Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
  6/23/2009; updated 4/2011
• FDA Asks Attention-Deficit Hyperactivity Disorder (ADHD) Drug Manufacturers to Develop Patient Medication Guides
  2/21/2007
• Adderall and Adderall XR (amphetamines) Information
• Atomoxetine (marketed as Strattera) Information
• Information for Healthcare Professionals: Cylert (pemoline) Tablets and Chewable Tablets
  10/2005

Contact FDA